Boston Scientific
NYSE:BSXBoston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Marathon Gold
TSE:MOZMarathon Gold Corporation acquires, explores for, and develops mineral resource projects in Canada. The company explores for gold, and precious and base metal deposits. Its flagship property is the Valentine Lake gold property with five mineralized deposits located in Central Region of Newfoundland and Labrador, Canada. The company was incorporated in 2009 and is headquartered in Toronto, Canada.
Pure Technologies
TSE:PURPure Technologies Ltd. (Pure) is engaged in the development and application of technologies for inspection, monitoring and management of physical infrastructure, including water and hydrocarbon pipelines, buildings and bridges. The Company's segments include Americas, International and PureHM. Its technologies include SoundPrint acoustic monitoring technology, which is used to provide continuous remote health monitoring of water and wastewater pipelines, bridges, buildings, parking structures and other infrastructure components; SoundPrint Acoustic Fibre-Optic (AFO) technology, which is a fiber-optic monitoring system used for structural monitoring of prestressed concrete water and wastewater pipelines, and Armadillo Tracks Remote Tracking Units, which is a PureHM technology and an Internet based pig tracking and pipeline monitoring system that integrates acoustic geophones, magnetic sensors and other technologies to monitor pipelines for pig passages and environmental changes.